Thomas J Rutkoski

Affiliations

Deciphera Pharmaceuticals, Inc., Waltham, MA 02451, USA.

Publications (1)

Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants.

Cancer cell

Avec: Bryan D Smith , Michael D Kaufman , Wei-Ping Lu , Anu Gupta , Cynthia B Leary , Scott C Wise , Yu Mi Ahn , Gada Al-Ani , Stacie L Bulfer , Timothy M Caldwell , Lawrence Chun , Carol L Ensinger , Molly M Hood , Arin McKinley , William C Patt , Rodrigo Ruiz-Soto , Ying Su , Hanumaiah Telikepalli , Ajia Town , Benjamin A Turner , Lakshminarayana Vogeti , Subha Vogeti , Karen Yates , Filip Janku , Albiruni Ryan Abdul Razak , Oliver Rosen , Michael C Heinrich , Daniel L Flynn

Réseau de co-auteurs

Bryan D Smith 1 collaboration

Michael D Kaufman 1 collaboration

Wei-Ping Lu 1 collaboration

Anu Gupta 1 collaboration

Cynthia B Leary 1 collaboration

Scott C Wise 1 collaboration

Yu Mi Ahn 1 collaboration

Gada Al-Ani 1 collaboration

Stacie L Bulfer 1 collaboration

Timothy M Caldwell 1 collaboration

Lawrence Chun 1 collaboration

Carol L Ensinger 1 collaboration

Molly M Hood 1 collaboration

Arin McKinley 1 collaboration

William C Patt 1 collaboration

Rodrigo Ruiz-Soto 1 collaboration

Ying Su 1 collaboration

Hanumaiah Telikepalli 1 collaboration

Ajia Town 1 collaboration

Benjamin A Turner 1 collaboration

Lakshminarayana Vogeti 1 collaboration

Subha Vogeti 1 collaboration

Karen Yates 1 collaboration

Filip Janku 1 collaboration

Albiruni Ryan Abdul Razak 1 collaboration

Oliver Rosen 1 collaboration

Michael C Heinrich 1 collaboration

Daniel L Flynn 1 collaboration